Rob has been advising on corporate finance transactions for over ten years. He focuses on equity capital markets, frequently acting for issuers and banks on IPOs, follow-on offerings, takeovers, step-ups and general listed company transactions.
Rob also regularly advises on M&A transactions, acting for both private and public companies with a particular focus on cross-border transactions, as well as venture capital and private equity transactions, including investments, MBOs, secondary buyouts, exits and debt/equity reorganisations.
Alongside the transactional matters, Rob also regularly advises on joint ventures and corporate partnerships both in the private and public sector. He is a member of our Boardroom Advisory Services group, frequently advising on ESG related matters and how to treat trust and reputation as a balance sheet asset. Rob is a member of the global Life Sciences sector, heading up this sector in the Birmingham office. He acts for a number of listed and unlisted life sciences companies and regularly publishes articles on the sector. Rob is also prominent in the real estate sector, commonly advising on joint venture and corporate structures through which real estate projects are established, developed and delivered.
Rob is a member of the London Stock Exchange’s Regional Advisory Group and an honorary lecturer at the University of Birmingham. He also regularly volunteers and speaks at local incubators, offering pro bono advice to start-ups looking for a hand-up, particularly in the Life Sciences sector.
